Darya-Varia Laboratoria Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Darya-Varia Laboratoria Tbk PT with three other
pharmaceutical manufacturers in Asia:
Ginwa Enterprise Group Inc.
sales of 666.08 million Chinese Renmimbi [US$105.14 million]
of which 73%
was Pharmaceutical Industry),
Wakamoto Pharmaceutical Co., Ltd.
(11.18 billion Japanese Yen [US$105.46 million]
of which 51%
was Medical Pharmaceutical Products), and
Shanghai Fudan Forward S&T Co Ltd
based in China
(670.57 million Chinese Renmimbi [US$105.85 million]
of which 56%
During the year ended December of 2016, sales at
Darya-Varia Laboratoria Tbk PT were 1.45 trillion Indonesian Rupiahs (US$105.51 million).
increase of 11.1%
versus 2015, when the company's sales were 1.31 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Darya-Varia Laboratoria Tbk PT
(and since 2011, sales have increased a total of 49%).
Sales of Consumer Health saw an increase
that was more than double the company's growth rate: sales were up
50.2% in 2016, from
434.58 billion Indonesian Rupiahs to 652.63 billion Indonesian Rupiahs.
Not all segments of Darya-Varia Laboratoria Tbk PT experienced an increase in sales in 2016:
sales of Prescribed Medicines fell 17.3% to 479.51 billion Indonesian Rupiahs.